Novo Nordisk CEO Grilled by Congress Over Price of Ozempic

WEDNESDAY, Sept. 25, 2024 -- During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company's high prices for its blockbuster drugs Ozempic and Wegovy.

While...